Photo: Ousa Chea, Unsplash

The UK Academy of Medical Sciences recommends major changes in how medical research is managed and communicated and the importance of scientific evidence in decision making.


The disturbing discovery that only about one third of the UK population trusted medical evidence and that two-thirds relied on the opinions of friends and family as their preferred sources of information, runs through a major new report by the UK Academy of Medical Sciences. Recent controversies around the benefits and harms of treatments such as statins, hormone replacement therapy and Tamiflu also highlighted the need for action.

“Enhancing the use of scientific evidence to judge the potential benefits and harms

of medicines” was published in June this year. It is the result of ‘a project to examine how the generation, trustworthiness and communication of scientific evidence can be enhanced to strengthen its role in decisions by patients, carers, healthcare professionals and others about the benefits and harms of medicines.’ These are some of the headline proposals to address real and perceived weaknesses in medical research, evidence and their communication:

  • Involvement of patients, carers and the wider public in research
  • Enhanced training in research methods and use of statistics
  • Support for new study designs and new methodologies, such as health apps and wearable technologies
  • The provision of evidence that is accessible, assessable and usable by the intended audience
  • Frameworks in which researchers can declare and manage interests
  • Presentation of scientific evidence in a clear, accessible and usable way
  • Improvements in patient information leaflets to include a balanced and easily understandable appraisal of medicines
  • A ‘traffic light’ system for press releases indicating how likely the research is to improve clinical practice in the near future and the robustness of the research
  • Codes of practice for all generators and communicators of research evidence to convey accurate, assessable and balanced information to the public.

There is also a proposal that a single, reliable, high profile, go-to destination for clear, up-to-date and evidence-based information should be strongly promoted; in the UK, this would be the NHS Choices website.

Among the excellent materials accompanying the report are 90-second videos illustrating the main points, social media posts and beautifully designed short summary documents of major recommendations, including one that lists questions patients should ask their doctors when discussing their medicines, and an accessible 8-page summary version of the long and complex report.

A short summary like this does not do justice to the depth and significance of the issues being addressed, nor the reforms being proposed, but it is clear that implementation of the recommendations would have a radical effect on how research is conducted, how evidence is communicated, and how well patients and their health professionals are supported in making the best decisions about medicines. The presentation of the report and its accompanying materials are also fine examples of good communication practice in action.

Read more:

 

Bruce Hugman
Communications Consultant, UMC

You may also like


The pharmacovigilance success story that started with a pandemic

Since 2020, the ICPV has worked to improve drug safety reporting at Instituto Nacional de Cardiología Ignacio Chávez, with promising outcomes.

16 October 2025

ISoP Latin American chapter pushes forward medicines safety innovation

More than 200 participants gathered in Mérida, Mexico, to discuss regional cooperation and emerging technologies in medicines safety across Latin America.

09 October 2025

Ensuring vaccine safety through improved reporting systems

Efforts to strengthen vaccine safety are advancing through better reporting tools, targeted training, and improved monitoring of adverse events.

03 October 2025